Multiple Myeloma News
- Convalescent Plasma Saves Lives in Blood Cancer and COVID-19
June 21, 2021 — Convalescent plasma, obtained from people who have had COVID-19 and have recovered, provides such patients with antibodies.
- Cancer Vaccine Shows Early Promise Across Tumor Types
April 16, 2021 — A personalized cancer vaccine proved possible to manufacture and was well tolerated in an early phase I clinical trial, researchers said.
- First CAR T-Cell Therapy for Multiple Myeloma: Abecma
March 29, 2021 — Ide-cel is the first CAR T-cell therapy to gain approval for use in multiple myeloma. It is also the first CAR T-cell therapy to target B-cell maturation antigen.
- Multiple Myeloma Drug Investigated for COVID
January 27, 2021 — An experimental drug for multiple myeloma may work on the coronavirus, a new study shows.
- Multiple Myeloma Responds to CAR T-Cell Therapy
December 9, 2020 — For patients with heavily-pretreated multiple myeloma, the strong responses seen with the new CAR T-cell treatment have also been prolonged.
- Gene-Based Therapy May Thwart a Tough Blood Cancer
June 5, 2017 — Researchers attempt to turn immune cells into unerring killers of multiple myeloma cells
- Drug Trio Shows Major Promise Against Myeloma
October 6, 2016 — 43 percent of study patients with the blood cancer had a complete response, researchers report
- Myeloma Drug Added Earlier in Treatment Promising
June 6, 2016 — Response rate doubled for patients with this blood cancer, study finds
- New Drug Shows Potential for Blood Cancer
June 2, 2015 — Multiple myeloma patients saw survival gains when elotuzumab was added to treatment
- Newer Drug Helps Older Myeloma Patients
September 3, 2014 — Treatment may extend survival for patients over 65, researchers say
- Newsman Tom Brokaw Battling Blood Cancer
February 11, 2014 — Veteran TV journalist has multiple myeloma, which attacks white blood cells in bone marrow
- Bone Drug May Help Treat Multiple Myeloma
December 3, 2010 — Adding the intravenous bone drug Zometa to chemotherapy improves survival in patients with the blood cancer multiple myeloma, new research from the U.K. shows.
- Thalidomide OK'd for Multiple Myeloma
May 26, 2006 — The FDA has approved thalidomide -- a drug known to cause severe birth defects -- to help treat newly diagnosed multiple myeloma, a cancer of the bone marrow.
- Understanding Geraldine Ferraro's 'Blood Cancer'
June 19, 2001 — WebMD Asks the Experts About Multiple Myeloma and Thalidomide
- Giving the Immune System a Second Chance to Kill Cancers
April 30, 2001 — Scientists Use Tumor to Fight Tumor in Multiple Myeloma
- Controversial Drug Useful for Advanced Type of Bone Marrow Cancer
May 21, 2000 — Thalidomide, a drug notorious for producing birth defects in babies born to women who took it for morning sickness in the 1960s, is proving to be effective for people with advanced multiple myeloma, a cancer of the bone marrow.